SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000936392-08-000779
Filing Date
2008-12-24
Accepted
2008-12-24 13:37:47
Documents
5
Period of Report
2008-09-30

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM 10-K a50935e10vkza.htm 10-K/A 31872
2 EX-31.1 a50935exv31w1.htm EX-31.1 8436
3 EX-31.2 a50935exv31w2.htm EX-31.2 8720
4 EX-32.1 a50935exv32w1.htm EX-32.1 2685
5 EX-32.2 a50935exv32w2.htm EX-32.2 2728
  Complete submission text file 0000936392-08-000779.txt   55969
Mailing Address 101 ENTERPRISE SUITE 300 ALISO VIEJO CA 92656
Business Address 101 ENTERPRISE SUITE 300 ALISO VIEJO CA 92656 949-389-6700
AVANIR PHARMACEUTICALS (Filer) CIK: 0000858803 (see all company filings)

IRS No.: 330314804 | State of Incorp.: CA | Fiscal Year End: 0930
Type: 10-K/A | Act: 34 | File No.: 001-15803 | Film No.: 081270010
SIC: 2834 Pharmaceutical Preparations